(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol

Product Name: (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
CAS No.: 167354-41-8
Chemical Name: (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
Synonyms: CS-251;Zosuquidar;Unii-ab5K82X98y;Zosuquidar [inn];LY335979; ZOSUQUIDAR;LY335979; LY 335979; LY-335979;(2R)-Anti-5-[3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy]quinoline hydrochloride;(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol;1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-, (αR)-;1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-, (αR)-
CBNumber: CB12128765
Molecular Formula: C32H31F2N3O2
Formula Weight: 527.6
MOL File: 167354-41-8.mol

More

Less

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol Property

Boiling point:: 690.5±55.0 °C(Predicted)
Density: 1.36
storage temp.: -20°C
solubility: H2O: soluble4mg/mL, clear (warmed)
form: powder
pka: 13.94±0.20(Predicted)
color: white to beige

More

Less

Safety

Hazard Codes: Xi
Risk Statements: 36/37/38
Safety Statements: 26
WGK Germany: 3

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: SML1044
Product name: Zosuquidar hydrochloride
Purity: ≥98% (HPLC)
Packaging: 5mg
Price: $209
Updated: 2024/03/01

Sigma-Aldrich

Product number: SML1044
Product name: Zosuquidar hydrochloride
Purity: ≥98% (HPLC)
Packaging: 25mg
Price: $741
Updated: 2024/03/01

ApexBio Technology

Product number: A3956
Product name: Zosuquidar
Packaging: 50mg
Price: $1024
Updated: 2021/12/16

ApexBio Technology

Product number: A3956
Product name: Zosuquidar
Packaging: 100mg
Price: $1733
Updated: 2021/12/16

ChemScene

Product number: CS-0921
Product name: Zosuquidar
Purity: 98.33%
Packaging: 50mg
Price: $420
Updated: 2021/12/16

More

Less

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol Chemical Properties,Usage,Production

Uses

Treatment of multidrug resistance (modulator of Pgp resistance).

Definition

ChEBI: LSM-5782 is a carbopolycyclic compound.

Biological Activity

zosuquidar (ly335979) 3hcl is a novel and potent modulator of p-glycoprotein (p-gp) [1]. p-gp is wildly expressed in brain, liver, small intestine and tumor cells and acts as an efflux pump responsible for multidrug resistance in tumor cells. overexpression of pgp in tumors results in multidrug resistance (mdr) to structurally unrelated oncolytics [2].

Biochem/physiol Actions

Zosuqidar is a potent inhibitor of P-glycoprotein (P-gp, MDR1) a transporter protein that is a key modulator of cellular drug efflux. Zosuquidar sensitizes AML, and other cancer cell lines to cytotoxic drugs.

in vitro

in cem/vlb100 cells, ly335979 treatment (0.1 μm) fully restored the sensitivity to vinblastine, doxorubicin (dox), etoposide, and taxol. in cem/vlb100 plasma membranes, ly335979 blocked [3h]azidopinephotoaffinity labeling of the m(r) approximately 170,000 pgp and competitively inhibited equilibrium binding of [3h]vinblastine to pgp with the ki value of approximately 0.06 μm [3]. in all p-gp-expressing leukemia cell linesincluding k562/hht40, k562/hht90, k562/dox and hl60/dnr, zosuquidar completely or partially restored drug sensitivity. in primary aml blasts with active p-gp, zosuquidar enhanced the cytotoxicity of anthracyclines (daunorubicin, idarubicin, mitoxantrone) and gemtuzumabozogamicin (mylotarg)[4].

in vivo

in mice bearing p388/adr murine leukemia cells,treatment with ly335979 in combination with dox or etoposide significantly increased in life span with no apparent alteration of pharmacokinetics. in a mdr human non-small cell lung carcinoma nude mouse xenograft model, ly335979 enhanced the antitumor activity of taxol [3].

References

[1] cripe l d, uno h, paietta e m, et al. zosuquidar, a novel modulator of p-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the eastern cooperative oncology group 3999[j]. blood, 2010, 116(20): 4077-4085.
[2] chaudhary p m, roninson i b. expression and activity of p-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells[j]. cell, 1991, 66(1): 85-94.
[3] dantzig a h, shepard r l, cao j, et al. reversal of p-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, ly335979[j]. cancer research, 1996, 56(18): 4171-4179.
[3] tang r, faussat a m, perrot j y, et al. zosuquidar restores drug sensitivity in p-glycoprotein expressing acute myeloid leukemia (aml)[j]. bmc cancer, 2008, 8(1): 1.
[4] morschhauser f, zinzani p l, burgess m, et al. phase i/ii trial of a p-glycoprotein inhibitor, zosuquidar. 3hcl trihydrochloride (ly335979), given orally in combination with the chop regimen in patients with non-hodgkin's lymphoma[j]. leukemia & lymphoma, 2007, 48(4): 708-715.
[5] lê l h, moore m j, siu l l, et al. phase i study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours[j]. cancer chemotherapy and pharmacology, 2005, 56(2): 154-160.

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol Suppliers

China 39 Germany 1 The Netherlands 1 United States 10 Global 51

Musechem

Tel: +1-800-259-7612
Fax: +1-800-259-7612
Email: info@musechem.com
Country: United States
ProdList: 4660
Advantage: 60

InvivoChem

Tel: +1-708-310-1919 +1-13798911105
Fax: 708-557-7486
Email: sales@invivochem.cn
Country: United States
ProdList: 6391
Advantage: 58

Cckinase, Inc.

Tel: +1 (732)236-3202
Email: sales@cckinase.com
Country: United States
ProdList: 2738
Advantage: 58

TargetMol Chemicals Inc.

Tel: +8613564774135
Email: zijue.cai@tsbiochem.com
Country: United States
ProdList: 19885
Advantage: 58

ApexBio Technology

Tel: --
Fax: --
Email: sales@apexbt.com
Country: United States
ProdList: 6251
Advantage: 58

Wonda Science

Tel: --
Fax: --
Email: wonda@wondascience.com
Country: United States
ProdList: 2192
Advantage: 50

Selleck Chemicals LLC

Tel: --
Fax: --
Email: info@selleckchem.com
Country: United States
ProdList: 824
Advantage: 60

MedKoo Biosciences

Tel: --
Fax: --
Email: sale@medkoo.com
Country: United States
ProdList: 86
Advantage: 50

MedChemExpress

Tel: --
Fax: --
Email: sales@medchemexpress.com
Country: United States
ProdList: 6398
Advantage: 58

Riedel-de Haen AG

Tel: --
Fax: --
Country: United States
ProdList: 6773
Advantage: 87

More

Less

View Lastest Price from (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol manufacturers

Zhuozhou Wenxi import and Export Co., Ltd

Product: Zosuquidar 167354-41-8
Price: US $15.00-10.00/KG
Min. Order: 1KG
Purity: 99%+ HPLC
Supply Ability: Monthly supply of 1 ton
Release date: 2021-07-10

Zhuozhou Wenxi import and Export Co., Ltd

Product: Zosuquidar 167354-41-8
Price: US $15.00-10.00/KG
Min. Order: 1KG
Purity: 99%+ HPLC
Supply Ability: Monthly supply of 1 ton
Release date: 2021-07-09

167354-41-8, (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-olRelated Search:

ZOSUQUIDAR TRIHYSROCHLORIDE AZD 3759 ZOTAROLIMUS Zonisamide CYCLOHEPTENE 1,1-DIFLUORO-2-PHENYL-CYCLOPROPANE (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol 1,2-DIPHENYLCYCLOPROPANE (S)-3-(Piperazin-1-yl)propane-1,2-diol ZOSUQUIDAR HYDROCHLORIDE MS 073 ZOSUQUIDAR MONOHYDRATE 1-(DIBENZOSUBERYL)PIPERAZINE

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol

Zosuquidar

(2R)-Anti-5-[3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy]quinoline hydrochloride

Unii-ab5K82X98y

Zosuquidar [inn]

LY335979; ZOSUQUIDAR

CS-251

LY335979; LY 335979; LY-335979

2R)-1-{4-[(1aR,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl]-1-piperazinyl}-3-(5-quinolinyloxy)-2-propanol trihydrochloride

1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-, (αR)-

167354-41-8

C32H31F2N3O2